Medical Cannabis, from cultivation to pharmaceuticals; inspired by the patient.
DanCann Pharma challenge the status quo when developing and supplying medical cannabis, with focus on environment, consistency and quality.
DanCann Pharma A/S
DanCann Pharma A/S was founded in 2018 and is a Danish pharmaceutical biotechnology company powered by cannabinoids. DanCann Pharma is focused on discovering, developing, manufacturing, and commercializing of novel cannabinoid therapeutics in a broad range of disease areas.
IPO at Spotlight Stock Market
To accelerate and develop DanCann Pharma A/S we are now raising further capital with an Initial Public Offering (IPO) at Spotlight Stock Market. Join our journey – from idea to launch – and help us change the world.
Find out moreCultivation technique developed by NASA
Until now, the Medical Cannabis industry has been reliant on old, refurbished greenhouses and single-tier cultivation. Instead, DanCann Pharma is utilizing the principles of Vertical Farming and Controlled Environment Agriculture.
Find out moreRelease the true potential
DanCann Pharma has a differentiated approach to the industry, by targeting supply and research of rare cannabinoids (APIs) for new, unexplored treatment options.
Find out more